Newron Pharmaceuticals S.p.A. carries a market capitalization of 277.76M, placing it among publicly traded companies globally.
| Market Cap | 277.76M |
| Enterprise Value | N/A |
Newron Pharmaceuticals S.p.A.'s stock has gained approximately 80.89431% over the past 52 weeks. The 50-day moving average sits at 14.53, while the 200-day moving average is 18.38.
| Beta (5Y) | N/A |
| 52-Week Price Change | 80.89431% |
| 50-Day Moving Average | 14.53 |
| 200-Day Moving Average | 18.38 |
| Average Volume (20 Days) | N/A |